Benzodiazepines in pregnancy are contraindicated because they can cause CNS depression in the neonate and respiratory issues. Which outcome is associated with neonatal exposure to benzodiazepines?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

Benzodiazepines in pregnancy are contraindicated because they can cause CNS depression in the neonate and respiratory issues. Which outcome is associated with neonatal exposure to benzodiazepines?

Explanation:
Exposure to benzodiazepines during pregnancy can depress the newborn’s brain and breathing because these drugs enhance the inhibitory effects of GABA in the CNS. They cross the placenta and, since the neonate’s metabolism is immature, the drug effects can linger after birth, leading to respiratory depression and reduced muscle tone. This makes respiratory issues the most likely neonatal outcome with in utero exposure. Hypertension, hyperactivity, and jaundice are not typical direct consequences of neonatal exposure to benzodiazepines.

Exposure to benzodiazepines during pregnancy can depress the newborn’s brain and breathing because these drugs enhance the inhibitory effects of GABA in the CNS. They cross the placenta and, since the neonate’s metabolism is immature, the drug effects can linger after birth, leading to respiratory depression and reduced muscle tone. This makes respiratory issues the most likely neonatal outcome with in utero exposure.

Hypertension, hyperactivity, and jaundice are not typical direct consequences of neonatal exposure to benzodiazepines.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy